These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 33423829)

  • 1. Application of CMAP scan for the evaluation of patients with chronic inflammatory demyelinating polyneuropathy: a prospective study.
    Okhovat AA; Advani S; Moradi K; Ziaadini B; Panahi A; Nafissi S; Haghi Ashtiani B; Fatehi F
    Neurophysiol Clin; 2021 Mar; 51(2):175-181. PubMed ID: 33423829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes of clinical, neurophysiological and nerve ultrasound characteristics in CIDP over time: a 3-year follow-up.
    Fionda L; Di Pasquale A; Morino S; Leonardi L; Vanoli F; Loreti S; Garibaldi M; Lauletta A; Alfieri G; Bucci E; Salvetti M; Antonini G
    J Neurol; 2021 Aug; 268(8):3011-3019. PubMed ID: 33638679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The value of MUNIX as an objective electrophysiological biomarker of disease progression in chronic inflammatory demyelinating polyneuropathy.
    Okhovat AA; Advani S; Ziaadini B; Panahi A; Salehizadeh S; Nafissi S; Haghi Ashtiani B; Rajabally YA; Fatehi F
    Muscle Nerve; 2022 Apr; 65(4):433-439. PubMed ID: 35040150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Which nerve conduction parameters can predict spontaneous electromyographic activity in carpal tunnel syndrome?
    Chang CW; Lee WJ; Liao YC; Chang MH
    Clin Neurophysiol; 2013 Nov; 124(11):2264-8. PubMed ID: 23763989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compound muscle action potential duration ratio for differentiation between Charcot-Marie-Tooth disease and CIDP.
    Kitaoji T; Noto YI; Kojima Y; Tsuji Y; Kitani-Morii F; Mizuno T; Nakagawa M
    Clin Neurophysiol; 2023 Feb; 146():124-130. PubMed ID: 36608530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity-dependent hyperpolarization and conduction block in chronic inflammatory demyelinating polyneuropathy.
    Cappelen-Smith C; Kuwabara S; Lin CS; Mogyoros I; Burke D
    Ann Neurol; 2000 Dec; 48(6):826-32. PubMed ID: 11117538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Axonal damage determines clinical disability in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): A prospective cohort study of different CIDP subtypes and disease stages.
    Grüter T; Motte J; Bulut Y; Kordes A; Athanasopoulos D; Fels M; Schneider-Gold C; Gold R; Fisse AL; Pitarokoili K
    Eur J Neurol; 2022 Feb; 29(2):583-592. PubMed ID: 34687104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Criteria for demyelination based on the maximum slowing due to axonal degeneration, determined after warming in water at 37 degrees C: diagnostic yield in chronic inflammatory demyelinating polyneuropathy.
    Van Asseldonk JT; Van den Berg LH; Kalmijn S; Wokke JH; Franssen H
    Brain; 2005 Apr; 128(Pt 4):880-91. PubMed ID: 15689367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electrophysiological testing in chronic inflammatory demyelinating polyneuropathy patients treated with subcutaneous immunoglobulin: The Polyneuropathy And Treatment with Hizentra (PATH) study.
    Bril V; Hartung HP; Lawo JP; Durn BL; Mielke O
    Clin Neurophysiol; 2021 Jan; 132(1):226-231. PubMed ID: 33039291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution, clinical correlates and significance of axonal loss and demyelination in chronic inflammatory demyelinating polyneuropathy.
    Rajabally YA; Narasimhan M
    Eur J Neurol; 2011 Feb; 18(2):293-299. PubMed ID: 20602631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different Tendencies in Muscle Ultrasound Characteristic in Amyotrophic Lateral Sclerosis and Chronic Inflammatory Demyelinating Polyradiculoneuropathy.
    Hokkoku K; Tsukamoto H; Uchida Y; Gatto DM; Sonoo M
    J Clin Neurophysiol; 2023 Jul; 40(5):450-455. PubMed ID: 37399044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conduction block during and after ischaemia in chronic inflammatory demyelinating polyneuropathy.
    Cappelen-Smith C; Lin CS; Kuwabara S; Burke D
    Brain; 2002 Aug; 125(Pt 8):1850-8. PubMed ID: 12135975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolongation of the tibialis anterior CMAP duration in chronic inflammatory demyelinating polyneuropathy.
    Nodera H; Latov N; Carey B; Langsdorf J; Bedoya V; Tacheva S; Chin RL
    Clin Neurophysiol; 2012 Feb; 123(2):393-8. PubMed ID: 21767985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is total duration of distal compound muscle action potential better than negative peak duration in the diagnosis of chronic inflammatory demyelinating polyneuropathy?
    Lagarde J; Viala K; Fournier E
    Muscle Nerve; 2014 Jun; 49(6):895-9. PubMed ID: 24114712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blink R1 latency utility in diagnosis and treatment assessment of polyradiculoneuropathy-organomegaly-endocrinopathy-monoclonal protein-skin changes and chronic inflammatory demyelinating polyradiculoneuropathy.
    Wang W; Litchy WJ; Mauermann ML; Dyck PJB; Dispenzieri A; Mandrekar J; Dyck PJ; Klein CJ
    Muscle Nerve; 2018 Jan; 57(1):E8-E13. PubMed ID: 28646568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The electrophysiological response to immunoglobulin therapy in chronic inflammatory demyelinating polyneuropathy.
    Otto M; Markvardsen L; Tankisi H; Jakobsen J; Fuglsang-Frederiksen A
    Acta Neurol Scand; 2017 Jun; 135(6):656-662. PubMed ID: 27546708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electrophysiological features of POEMS syndrome and chronic inflammatory demyelinating polyneuropathy.
    Guo X; Qin X; Zhang Y; Huang C; Yu G
    J Clin Neurosci; 2014 Apr; 21(4):587-90. PubMed ID: 24268501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity-dependent conduction block in chronic inflammatory demyelinating polyneuropathy.
    Straver DC; van den Berg LH; Franssen H
    J Neurol Sci; 2011 Jan; 300(1-2):33-8. PubMed ID: 21035143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term neurophysiological and clinical response in patients with chronic inflammatory demyelinating polyradiculoneuropathy treated with subcutaneous immunoglobulin.
    Cirillo G; Todisco V; Tedeschi G
    Clin Neurophysiol; 2018 May; 129(5):967-973. PubMed ID: 29554579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrophysiologic correlations with clinical outcomes in CIDP.
    Bril V; Banach M; Dalakas MC; Deng C; Donofrio P; Hanna K; Hartung HP; Hughes RA; Katzberg H; Latov N; Merkies IS; Van Doorn PA;
    Muscle Nerve; 2010 Oct; 42(4):492-7. PubMed ID: 20665514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.